PCN62 Budget IMPACT Analysis of Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer in Argentina
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.199
https://www.valueinhealthjournal.com/article/S1098-3015(20)32455-4/fulltext
Title :
PCN62 Budget IMPACT Analysis of Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer in Argentina
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32455-4&doi=10.1016/j.jval.2020.08.199
First page :
Section Title :
Open access? :
No
Section Order :
10155